Earnings Feed
Start Free
Ventyx Biosciences, Inc.·4

Mar 4, 4:23 PM ET

GUJRATHI SHEILA 4

4 · Ventyx Biosciences, Inc. · Filed Mar 4, 2026

Insider Transaction Report

Form 4Exit
Period: 2026-03-04
Ventyx Biosciences, Inc.VTYX
GUJRATHI SHEILA
Director
Transactions
  • Disposition to Issuer

    Common Stock

    [F1][F2][F3]
    2026-03-04−130,000→ 0 total(indirect: See Footnote)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    [F1][F4]
    2026-03-04−33,000→ 0 total
    Exercise: $3.29Exp: 2034-06-06→ Common Stock (33,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    [F1][F4]
    2026-03-04−40,000→ 0 total
    Exercise: $2.25Exp: 2035-06-05→ Common Stock (40,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    [F1][F4]
    2026-03-04−80,000→ 0 total
    Exercise: $1.97Exp: 2034-01-21→ Common Stock (80,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    [F1][F4]
    2026-03-04−662,369→ 0 total
    Exercise: $6.03Exp: 2031-08-17→ Common Stock (662,369 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    [F1][F5]
    2026-03-04−277,941→ 0 total
    Exercise: $18.65Exp: 2031-12-02→ Common Stock (277,941 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    [F1][F5]
    2026-03-04−21,825→ 0 total
    Exercise: $16.54Exp: 2032-06-09→ Common Stock (21,825 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    [F1][F5]
    2026-03-04−15,937→ 0 total
    Exercise: $34.83Exp: 2033-06-08→ Common Stock (15,937 underlying)
Footnotes (5)
  • [F1]Pursuant to the Agreement and Plan of Merger, dated January 7, 2026 (as it may be amended from time to time, the "Merger Agreement"), by and among Ventyx Biosciences, Inc. ("Issuer") , Eli Lilly and Company ("Parent"), and Parent's wholly owned subsidiary, RYLS Merger Corporation ( "Merger Sub"), the Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger and becoming a wholly owned subsidiary of the Parent.
  • [F2]At the effective time of the Merger (the "Effective Time"), these shares were automatically converted solely into the right to receive cash in an amount equal to $14.00 (without interest) per share (the "Per Share Price"), subject to the terms and conditions of the Merger Agreement.
  • [F3]The shares are held by the Jordan Yechiel Cohen and Sheila Kumari Gujrathi AB Living Trust, for which the Reporting Person serves as a co-trustee.
  • [F4]At the Effective Time, this option to purchase shares of the Issuer's common stock had an exercise price per share that was less than or equal the Per Share Price and, pursuant to the terms of the Merger Agreement, at the Effective Time, was automatically cancelled and converted into the right to receive an amount in cash equal to (i) the total number of shares of common stock subject to the option, multiplied by (ii) the excess, if any, of the Per Share Price over the exercise price per share of such option, without interest and less any applicable withholding taxes.
  • [F5]At the Effective Time, this option to purchase shares of the Issuer's common stock was fully vested and had an exercise price per share that was greater than the Per Share Price and, pursuant to the terms of the Merger Agreement, at the Effective Time, was automatically cancelled for no consideration.
Signature
/s/ Austin Rutherford, as Attorney-in-Fact|2026-03-04

Documents

1 file
  • 4
    form4-03042026_090330.xmlPrimary